SeeTreat Medical

SeeTreat Medical is an Australian medical technology company founded in 2023 by Dr. Trang Nguyen and Professor Paul Keall. The company focuses on transforming oncology treatment through personalized and precise solutions, making advanced cancer care accessible to patients worldwide. Their mission is to eliminate economic barriers to personalized cancer treatments. The company specializes in innovative software for radiation oncology, particularly adaptive radiotherapy. Their flagship product, ART.1, is a software-as-a-medical-device that automates daily dose evaluation and supports treatment replanning without disrupting existing workflows. This tool enhances clinical efficiency and patient outcomes by prioritizing cases that need attention. SeeTreat aims to integrate effective adaptive-quality treatment capabilities into standard linear accelerators, making advanced radiotherapy more affordable for clinics globally. Led by a team of experienced researchers and clinicians, SeeTreat emphasizes collaboration and innovation in its product development. Their software solutions are designed for radiation oncology clinics and healthcare providers looking to improve treatment precision and patient quality of life.

• Employees 26